TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 133 filers reported holding TRANSLATE BIO INC in Q2 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.4%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Advisors, Inc. | 3,922,008 | $29,415,000 | 15.52% |
| Omega Fund Management, LLC | 2,437,603 | $18,282,000 | 13.56% |
| DAFNA Capital Management LLC | 228,939 | $1,717,000 | 0.85% |
| Baupost Group | 6,491,287 | $47,136,000 | 0.41% |
| Rock Springs Capital Management LP | 1,009,179 | $7,569,000 | 0.36% |
| Bain Capital Public Equity Management, LLC | 416,670 | $3,125,000 | 0.29% |
| Cormorant Asset Management, LP | 454,550 | $3,409,000 | 0.28% |
| SPHERA FUNDS MANAGEMENT LTD. | 309,400 | $2,321,000 | 0.26% |
| Artal Group S.A. | 600,000 | $4,500,000 | 0.17% |
| Perceptive Advisors | 435,000 | $3,167,000 | 0.12% |